Ashley Wohl, a 20-year-old woman with Spinal Muscular Atrophy, type 2, worked with Gillette Children's specialists to prepare for her future as a college student at North Dakota University.

A new pediatric neurologist at Gillette Children's discovered a passion for her field while eating a slice of pizza. Jamie Eskuri, MD, is excited to begin working with Gillette families and to be back in the state she considers home.

The U.S. Food Drug Administration’s (FDA’s) recent approval of a new oral medication to help treat spinal muscular atrophy (SMA) is being hailed as a “game changer” by Gillette Children's neurologist, Randal Richardson, MD, MMS. “The main message I want to get out to people who have SMA and their families is—many of you now have options and the power to make a choice for yourself,” Richardson says.